Skip to content

Nasopharyngeal airway vs nasal cannula in EBUS

Oxygen Insufflation Through Nasopharyngeal Airway v/s Nasal Cannula During Anaesthesia In EBUS-TBNA Procedures. - OXYNAS-EBUS

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020043
Enrollment
40
Registered
2019-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C399- Malignant neoplasm of lower respiratory tract, part unspecified

Interventions

Intervention1: Oxygenation through Nasopharyngeal airway and attachment of Anesthesia circuit with a suitable connector.: After lubricating with application of lignocaine jelly, Nasopharyngeal Airway

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age less than or equal to 18 years BMI less than 30 ASA physical Status I - III Able to give informed consent Planned for sedation

Exclusion criteria

Exclusion criteria: Age less than 18 years Refusal or unable to consent Trachea intubated or requiring intubation for procedure Pregnant females Active nasal bleeding Nasal, nasopharyngeal or base of skull pathology Patient with baseline saturation less than 92%

Design outcomes

Primary

MeasureTime frame
The proportion of patients experiencing desaturation below 92% during the procedure.Timepoint: From administering sedation to the end of the procedure.

Secondary

MeasureTime frame
1.Lowest SpO2 during the procedure 2.Number of hypoxic episodes (SpO2 below 92%) during the procedure in individual patients 3.Duration of hypoxia during the procedure in seconds 4.Any complications, including number of interruptions to procedure to allow anaesthetic intervention, arrhythmia, myocardial ischaemia and cardiac arrest. 5.Number of patients requiring insertion of definitive airway 6.Incidence of dryness of nasal mucosa, dry throat/irritation, retained secretionsTimepoint: Data will be collected at an interval of 5 minutes after start of the procedure if it is uneventful. Continuous monitoring for oxygen saturation and complications, if any, will be done in addition to the fixed 5 minutes interval.

Countries

India

Contacts

Public ContactNeha Desai

Tata Medical Center

dr.nehadesai@gmail.com9748988073

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026